Magenta Therapeutics, Inc.MGTANASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+34.1%
5Y CAGR+16.7%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+34.1%/yr
vs +20.2%/yr prior
5Y CAGR
+16.7%/yr
Recent acceleration
Acceleration
+13.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.2x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $179.97M | +66.5% |
| 2024 | $108.10M | +33.6% |
| 2022 | $80.90M | +8.3% |
| 2021 | $74.69M | -5.1% |
| 2020 | $78.70M | -5.1% |
| 2019 | $82.97M | +38.4% |
| 2018 | $59.96M | +67.8% |
| 2017 | $35.73M | +285.5% |
| 2016 | $9.27M | - |